A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases - Summary - MDSpire
Advertisement
A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases
Physicians at Fox Chase Cancer Center have begun accepting patients for a new clinical trial looking at the effectiveness of a hepatic artery infusion (HAI) pump along with standard chemotherapy. Fox Chase is the only local hospital offering this trial, which is designed for patients with colorectal cancer that has spread to the liver and cannot be treated with surgery.
To evaluate the effectiveness of a hepatic artery infusion (HAI) pump combined with standard chemotherapy for patients with colorectal cancer that has metastasized to the liver and is inoperable.
Key Findings:
HAI pumps have shown potential in shrinking liver metastases and may enable subsequent surgical options.
The trial aims to replicate positive outcomes observed in earlier studies.
Interpretation:
The study seeks to improve survival rates for patients with inoperable liver metastases by potentially making surgery a viable option through enhanced chemotherapy delivery.
Limitations:
Limited prior trials on HAI pumps since the early 2000s.
Results may vary based on individual patient responses.
Conclusion:
The PUMP Trial at Fox Chase Cancer Center represents a significant effort to enhance treatment options for colorectal cancer patients with liver metastases.
